Clincosm LogoSign in Get a demo

chronic myeloid leukemia

Showing 1 - 25 of 224
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Real-World Usage of Asciminib Among Chronic Myeloid Leukemia in

Completed
  • Chronic Myeloid Leukemia
    • East Hanover, New Jersey
      Novartis
    Nov 20, 2023

    3rd Line Therapy or More to Treat Adult CML- CP in Real World

    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Asciminib
    • (no location specified)
    Oct 16, 2023

    Concomitant Medications at CML Diagnosis

    Completed
    • Chronic Myeloid Leukemia
    • the prevalence of comorbid conditions
    • (no location specified)
    Sep 16, 2023

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • +10 more
    • Jacksonville, Florida
    • +5 more
    Aug 14, 2023

    Asciminib RMP Study

    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Asciminib
    • (no location specified)
    Jul 5, 2023

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • +6 more
    • Miltenyi CliniMACS Prodigy ® system
    • (no location specified)
    Mar 23, 2023

    Chronic Myeloid Leukemia Trial in France (Venetoclax)

    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Amiens, France
    • +14 more
    Mar 3, 2023

    Tyrosine Kinase Inhibitors, Chronic Myeloid Leukemia Trial in Poitiers (treatment of TKI in CML)

    Not yet recruiting
    • Tyrosine Kinase Inhibitors
    • Chronic Myeloid Leukemia
    • treatment of TKI in CML
    • Poitiers, France
      Chu Poitiers
    Feb 21, 2023

    Nilotinib for Chronic Myeloid Leukemia in First Line and Any

    Completed
    • Chronic Myeloid Leukemia
    • Nilotinib
    • Freudenstadt, Baden Wuerttemberg, Germany
    • +76 more
    Feb 9, 2023

    Chronic Myeloid Leukemia Trial in Italy (Bosutinib)

    Completed
    • Chronic Myeloid Leukemia
    • Alessandria, Italy
    • +44 more
    Feb 2, 2023

    Chronic Myeloid Leukemia Trial in Jena (Venetoclax)

    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Jena, Germany
      Universitätsklinikum Jena
    Jan 17, 2023

    Colorectal Cancer, Hematologic Malignancy, Rectum Cancer Trial in Cleveland (Vactosertib, Fludarabine Phosphate,

    Recruiting
    • Colorectal Cancer
    • +11 more
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Jan 18, 2023

    Chronic Myeloid Leukemia Trial (Asciminib)

    Available
    • Chronic Myeloid Leukemia
    • (no location specified)
    Jan 17, 2023

    Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

    Suspended
    • Juvenile Myelomonocytic Leukemia
    • +27 more
    • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 11, 2023

    Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, MDS Trial in Houston (CliniMACS)

    Not yet recruiting
    • Acute Lymphoblastic Leukemia in Remission
    • +10 more
    • CliniMACS
    • Houston, Texas
    • +1 more
    Dec 8, 2022

    Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Multiple Chronic Conditions Trial in Ann Arbor (Patient Reported Outcome

    Terminated
    • Chronic Myeloid Leukemia
    • +2 more
    • Patient Reported Outcome Measure (PROM)
    • +2 more
    • Ann Arbor, Michigan
      University of Michigan Rogel Cancer Center
    Nov 21, 2022

    Myeloid Malignancies, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (Cyclophosphamide, Mesna, Filgrastim)

    Recruiting
    • Myeloid Malignancies
    • +3 more
    • Houston, Texas
      M D Anderson Caner Center
    Nov 17, 2022

    Needs of 3L+ CP-CML and With T315I-mutated CML Patients

    Completed
    • Chronic Myeloid Leukemia
    • 3L Therapy
    • T315I
    • Lyon, France
      Novartis Investigative Site
    Nov 9, 2022

    3L+ Therapies Among Chronic Myeloid Leukemia and Those With

    Completed
    • Chronic Myeloid Leukemia
      • East Hanover, New Jersey
        Novartis Investigative Site
      Nov 11, 2022

      According to Molecular Identification at Diagnosis

      Not yet recruiting
      • Chronic Myeloid Leukemia
      • Next Generation Sequencing (DNA and RNA)
      • (no location specified)
      Oct 28, 2022

      Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Small Lymphocytic Lymphoma Trial in Baltimore (Fludarabine,

      Completed
      Has Results
      • Myelodysplastic Syndrome
      • +13 more
      • Baltimore, Maryland
        Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
      Nov 2, 2022

      CML Patients in the National Compassionate Program

      Terminated
      • Chronic Myeloid Leukemia
      • Philadelphia Positive
      • Bari, Italy
      • +9 more
      Oct 24, 2022

      Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

      Recruiting
      • Adenocarcinoma
      • +75 more
      • Biomarker Testing (L)
      • +2 more
      • Idaho Falls, Idaho
      • +1 more
      Oct 18, 2022

      Leukemia, Acute Myeloid, MDS, Classical Hodgkin Lymphoma Trial in United States (MGD024)

      Recruiting
      • Leukemia, Acute Myeloid
      • +7 more
      • Denver, Colorado
      • +4 more
      Aug 29, 2022

      Chronic Myeloid Leukemia Trial in Worldwide (ELVN-001)

      Recruiting
      • Chronic Myeloid Leukemia
      • New York, New York
      • +22 more
      Aug 15, 2022